The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Eagle Pharmaceuticals, Inc(NASDAQ:EGRX) 
Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for ch...
Website: http://www.eagleus.com
Founded: 2007
Full Time Employees: 108
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Eagle Pharmaceuticals Days Payable Outstanding ttm (DPO)
Eagle Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Eagle Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Eagle Pharmaceuticals Op Cashflow Per Share ttm
Eagle Pharmaceuticals Free Cashflow Per Share ttm
Eagle Pharmaceuticals Cash Per Share ttm
Eagle Pharmaceuticals P/S ratio ttm
Eagle Pharmaceuticals (GAAP) P/E ratio ttm
Eagle Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.